Are you developing a digital medical device and wondering about the market access pathways in France (permanent and derogative pathways), when to anticipate them, and how to implement them in practice?
We are pleased to invite you to a dedicated webinar to provide a concrete, operational, and pragmatic perspective on the various strategies for valuing and financing digital or innovative medical devices.
Webinar Objectives:
- Understanding the different permanent and derogative market access pathways
- Identifying financing options adapted to your solution and business model, and when to activate them
- Identifying key regulatory, economic, and strategic considerations
- Gaining concrete feedback from project leaders who have successfully navigated these stages
PROGRAMME
Analysis of possible pathways for digital medical devices
Regulatory, economic, and strategic considerations (challenges and timelines to anticipate)
Feedback from sector startups
Discussion session with participants
SPEAKERS
- Sandrine Baffert, General Manager and HEOR Director, CEMKA
- Lauriane Villemur, Market Access & Pricing Director, CEMKA
- Coralie Lefevre, CEO, Diappymed
This webinar is reserved for Eurobiomed members.
SPONSORED BY
